Dashboard
Manage Tickers

CYT CYTEC INDUSTRIES INC/DE/

NYSE http://www.cytec.com


$ 0.02 (0.03 %)    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 633.20 $ -9.72 (-1.53 %)
DIA $ 475.83 $ -1.36 (-0.29 %)
SPY $ 684.43 $ -7.56 (-1.1 %)
TLT $ 90.42 $ -0.53 (-0.58 %)
GLD $ 371.67 $ 7.13 (1.96 %)
$ 75.17
-- x --
-- x --
-- - --
$ 42.16 - $ 75.20
1,067,107
na
5.38B
$ 1.21
$ 42.22
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-22-2015 09-30-2015 10-Q
2 07-20-2015 06-30-2015 10-Q
3 04-20-2015 03-31-2015 10-Q
4 02-24-2015 12-31-2014 10-K
5 10-20-2014 09-30-2014 10-Q
6 07-21-2014 06-30-2014 10-Q
7 04-23-2014 03-31-2014 10-Q
8 02-21-2014 12-31-2013 10-K
9 10-31-2013 09-30-2013 10-Q
10 08-02-2013 06-30-2013 10-Q
11 05-03-2013 03-31-2013 10-Q
12 02-25-2013 12-31-2012 10-K
13 11-08-2012 09-30-2012 10-Q
14 08-06-2012 06-30-2012 10-Q
15 04-24-2012 03-31-2012 10-Q
16 02-24-2012 12-31-2011 10-K
17 10-25-2011 09-30-2011 10-Q
18 07-28-2011 06-30-2011 10-Q
19 04-25-2011 03-31-2011 10-Q
20 02-24-2011 12-31-2010 10-K
21 10-28-2010 09-30-2010 10-Q
22 07-28-2010 06-30-2010 10-Q
23 04-26-2010 03-31-2010 10-Q
24 02-24-2010 12-31-2009 10-K
25 10-28-2009 09-30-2009 10-Q
26 07-30-2009 06-30-2009 10-Q
27 04-30-2009 03-31-2009 10-Q
28 02-26-2009 12-31-2008 10-K
29 10-30-2008 09-30-2008 10-Q
30 07-31-2008 06-30-2008 10-Q
31 05-01-2008 03-31-2008 10-Q
32 02-28-2008 12-31-2007 10-K
33 10-31-2007 09-30-2007 10-Q
34 08-01-2007 06-30-2007 10-Q
35 05-02-2007 03-31-2007 10-Q
36 02-28-2007 12-31-2006 10-K
37 11-02-2006 09-30-2006 10-Q
38 08-02-2006 06-30-2006 10-Q
39 05-03-2006 03-31-2006 10-Q
40 02-28-2006 12-31-2005 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

the-official-delisting-of-cyteirs-common-stock-will-be-effective-on-or-about-march-28-2024-ten-days-after-the-filing-of-the-form-25
The Official Delisting Of Cyteir's Common ...
03/07/2024 21:53:55

cyteir-announces-on-or-about-march-18-2024-the-trading-of-the-common-stock-on-nasdaq-be-suspended-effective-before-the-market-opens
Cyteir Announces On Or About March 18, 202...
03/07/2024 21:53:37

Cyteir Therapeutics, Inc. ("Cyteir") (NASDAQ:CYT) today announced that it has formally notified The Nasdaq Stock Market...

b-of-a-securities-downgrades-cyteir-therapeutics-to-underperform-announces-3-price-target
B of A Securities Downgrades Cyteir Therap...
01/05/2024 16:14:19

B of A Securities analyst Tazeen Ahmad downgrades Cyteir Therapeutics (NASDAQ:CYT) from Neutral to Underperform and announce...

cyteir-therapeutics-presented-ongoing-results-from-a-dose-expansion-cohort-of-cyt-0851-in-combination-with-capecitabine-in-advanced-platinum-resistant-ovarian-cancer
Cyteir Therapeutics Presented Ongoing Resu...
10/12/2023 11:36:23

Cyteir Therapeutics, Inc. ("Cyteir") (NASDAQ:CYT) today presented ongoing results from a dose expansion cohort in its P...

nasdaq-jumps-200-points-baudax-bio-shares-spike-higher
Nasdaq Jumps 200 Points; Baudax Bio Shares...
06/30/2023 18:34:18

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 1.5% on Friday. The Dow traded u...

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
06/30/2023 17:37:38

why-cineverse-shares-are-trading-lower-by-18-here-are-other-stocks-moving-in-fridays-mid-day-session
Why Cineverse Shares Are Trading Lower By ...
06/30/2023 16:34:37

Gainers Addentax Group Corp. (NASDAQ: ATXG) shares jumped 47.3% to $9.68. Addentax Group is launching automation of artifici...

crude-oil-rises-over-1-feds-preferred-inflation-gauge-slows-in-may
Crude Oil Rises Over 1%; Fed's Preferred I...
06/30/2023 16:01:22

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 1% on Friday. The Dow traded up ...

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
06/30/2023 13:12:33

cyteir-therapeutics-announces-discontinuation-of-cyt-0851-development-program-and-planned-liquidation-and-dissolution
Cyteir Therapeutics Announces Discontinuat...
06/30/2023 12:07:58

Cyteir Therapeutics, Inc. ("Cyteir" or the "Company") (NASDAQ:CYT) today announced that it is discontinuing all...

wedbush-reiterates-outperform-on-cyteir-therapeutics-maintains-3-price-target
Wedbush Reiterates Outperform on Cyteir Th...
05/12/2023 13:52:09

Wedbush analyst Robert Driscoll reiterates Cyteir Therapeutics (NASDAQ:CYT) with a Outperform and maintains $3 price target.

cyteir-therapeutics-q4-eps-025-beats-034-estimate
Cyteir Therapeutics Q4 EPS $(0.25) Beats $...
03/23/2023 20:20:24

Cyteir Therapeutics (NASDAQ:CYT) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(...

cyteir-therapeutics-promotes-david-gaiero-to-chief-financial-officer
Cyteir Therapeutics Promotes David Gaiero ...
02/06/2023 13:16:53

David was previously Vice President of Finance at Cyteir.

Core News & Articles
Benzinga's Top Ratings Upgrades, Downgrade...
02/03/2023 15:00:42

morgan-stanley-downgrades-cyteir-therapeutics-to-underweight-lowers-price-target-to-2
Morgan Stanley Downgrades Cyteir Therapeut...
02/03/2023 11:20:44

Morgan Stanley analyst Jeffrey Hung downgrades Cyteir Therapeutics (NASDAQ:CYT) from Equal-Weight to Underweight and lowers ...

Core News & Articles
Benzinga's Top Ratings Upgrades, Downgrade...
01/30/2023 15:00:50

b-of-a-securities-downgrades-cyteir-therapeutics-to-neutral-lowers-price-target-to-2
B of A Securities Downgrades Cyteir Therap...
01/30/2023 12:17:59

B of A Securities analyst Tazeen Ahmad downgrades Cyteir Therapeutics (NASDAQ:CYT) from Buy to Neutral and lowers the price ...

benzingas-top-ratings-upgrades-downgrades-for-january-20-2023
Benzinga's Top Ratings Upgrades, Downgrade...
01/20/2023 15:00:42

jp-morgan-downgrades-cyteir-therapeutics-to-neutral
JP Morgan Downgrades Cyteir Therapeutics t...
01/20/2023 09:54:40

JP Morgan analyst Anupam Rama downgrades Cyteir Therapeutics (NASDAQ:CYT) from Overweight to Neutral.

cyteir-therapeutics-announces-prioritization-of-cyt-0851-development-extended-cash-runway
Cyteir Therapeutics Announces Prioritizati...
01/19/2023 21:31:41

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION